Zsa Zsa Weerts

Addendum 274 Weerts ZZRM , Masclee AAM, Witteman BJM, Clemens CHM, Winkens B, Brouwers J, Frijlink HW, Muris JWM, De Wit NJ, Essers BAB, Tack J, Snijkers JTW, Bours AMH, de Ruiter-van der Ploeg AS, Jonkers DMAE, Keszthelyi D. Efficacy and Safety of Peppermint Oil in a Randomized, Double-Blind Trial of Patients With Irritable Bowel Syndrome. Gastroenterology, 2020, 158(1), 123-136. Mujagic Z, Weerts ZZRM , Vork L, Leue C, Kruimel JW, Hesselink M, Muris JWM, Jonkers DMAE, Masclee AAM, Keszthelyi D. Quality of life in irritable bowel syndrome: Authors' reply. Neurogastroenterology & Motility, 2020, 32(1), e13729. Weerts ZZRM * , Vork L * , Mujagic Z, Keszthelyi D, Hesselink MAM, Kruimel J, Leue C, Muris JWM, Jonkers DMAE, Masclee AAM. Reduction in IBS symptom severity is not paralleled by improvement in quality of life in patients with irritable bowel syndrome. Neurogastroenterology & Motility, 2019, 31(8), e13629. Weerts ZZRM , Keszthelyi D, Vork L, Aendekerk NCP, Frijlink HW, Brouwers J, Neef C, Jonkers DMAE, Masclee AAM. A Novel Ileocolonic Release Peppermint Oil Capsule for Treatment of Irritable Bowel Syndrome: A Phase I Study in Healthy Volunteers. Advances in Therapy, 2018, 35(11), 1965-1978. Beckers AB, Weerts ZZRM , Masclee AAM, Keszthelyi D. Letter: the neglected analgesic properties of red pepper in the clinical management of the irritable bowel syndrome pain-Authors' reply. Alimentary pharmacology & therapeutics, 2018, 47(1), 154-155. Weerts ZZRM * , Vork L * , Mujagic Z, Kruimel JW, Hesselink MAM, Muris JWM, Keszthelyi D, Jonkers DMAE, Masclee AAM. Rome III vs Rome IV criteria for irritable bowel syndrome: A comparison of clinical characteristics in a large cohort study. Neurogastroenterology & Motility, 2018, 30(2), e13189. Beckers AB, Weerts ZZRM , Helyes Z, Masclee AAM, Keszthelyi D. Review article: transient receptor potential channels as possible therapeutic targets in irritable bowel syndrome. Alimentary pharmacology & therapeutics, 2017, 46(10), 938-952. Mujagic Z, Jonkers DMAE, Ludidi S, Keszthelyi D, Hesselink MA, Weerts ZZRM , Kievit RN, Althof JF, Leue C, Kruimel JW, van Schooten FJ, Masclee AAM. Biomarkers for visceral hypersensitivity in patients with irritable bowel syndrome, Neurogastroenterology & Motility, 2017, 29(12), e13137.